-+ 0.00%
-+ 0.00%
-+ 0.00%

HLS Therapeutics Affirms FY2026 Sales Guidance of $56.000M-$60.000M vs $58.338M Est

Benzinga·11/12/2026 12:03:38
HLS Therapeutics (TSX:HLS) affirms FY2026 sales outlook from $56.000 million-$60.000 million to $56.000 million-$60.000 million vs $58.338 million estimate.